Agendia validates AI-based digital pathology approach in RASTER cohort

Oct 26, 2026 · Issue 13 · 3 sources, 3 articles

Agendia has published clinical validation of its AI-driven digital pathology assay, which showed high concordance with MammaPrint results in the prospective RASTER cohort of 372 patients with early-stage breast cancer. The news appeared on October 26.

Who is affected and how

doctor

Oncologists and pathologists may get a faster or cheaper risk-assessment alternative alongside genomic tests.

Sources

• Agendia Unveils Clinical Validation of AI-Driven Digital Pathology Approach - BioSpacebiospace.com · Oct 26, 2026
• Agendia Unveils Clinical Validation of AI-Driven Digital Pathology Approachbiospace · Oct 26, 2026
• Digital Pathology AI: The Accuracy–Clinical Utility Gappathologynews.com · Oct 28, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.